Bellicum Pharmaceuticals Next Earnings Date image   This BLCM next earnings date page last updated 3/21/2023
Bellicum Pharmaceuticals Next Earnings Date:4/4/2023
After close
(Projected earnings date)
Earnings Period:Q4 2022
Earnings Estimate:-0.930/share
Prior Q4 Earnings:0.110/share
Prior Q4 Revenue:0.00B
BLCM Listed On:NASDAQ
Comparative Importance of Bellicum Pharmaceuticals Next Earnings Date to the Market:

Next earnings date relative importance comparison
Next earnings date indicator BLCM

Also see: Bellicum Pharmaceuticals Earnings History
PeriodEarnings DateEarnings
Q3 202211/10/2022-0.230
Q2 20228/11/2022-0.130
Q1 20225/12/2022-0.250
Q4 20213/24/20220.110
Q3 202111/4/20210.070

Next Earnings Date Calendar:

Terran Orbital (LLAP): 3/21/2023 6:00 AM
X4 Pharmaceuticals (XFOR): 3/21/2023 6:00 AM
Biglari Holdings (BH): 3/21/2023 6:00 AM
Citi Trends (CTRN): 3/21/2023 6:45 AM
Resolute Forest Products (RFP): 3/21/2023 7:00 AM
Albireo Pharma (ALBO): 3/21/2023 8:00 AM
CinCor Pharma (CINC): 3/21/2023 8:00 AM
ProFrac Holding (ACDC): 3/21/2023 8:00 AM
MiNK Therapeutics (INKT): 3/21/2023 8:00 AM
Coupa Software (COUP): 3/21/2023 After close

More from the Next Earnings Dates Calendar

Earnings History:

Flotek Industries (FTK): 3/20/2023 After close
Ampco-Pittsburgh (AP): 3/20/2023 After close
Sanara MedTech (SMTI): 3/20/2023 After close
Exagen (XGN): 3/20/2023 After close
Graphite Bio (GRPH): 3/20/2023 After close
Canterbury Park Holding (CPHC): 3/20/2023 After close
Lantern Pharma (LTRN): 3/20/2023 After close
FAT Brands (FAT): 3/20/2023 After close
Radius Global Infr (RADI): 3/20/2023 After close
Movano (MOVE): 3/20/2023 8:30 AM

More from the Earnings History archive
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Quotes delayed 20 minutes

Email EnvelopeFree BLCM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Bellicum Pharmaceuticals (BLCM) is categorized under the Healthcare sector; to help you further research next earnings dates across stocks, below are some other companies in the same sector:

BLFS Next Earnings Date
BLI Next Earnings Date
BLPH Next Earnings Date
BLUE Next Earnings Date
BMEA Next Earnings Date
BMRA Next Earnings Date
BMRN Next Earnings Date
BMY Next Earnings Date

Bellicum Pharmaceuticals Next Earnings Date FAQ

When is the BLCM next earnings date?
I am following Bellicum Pharmaceuticals, under stock symbol BLCM, and I would like to know when is their next earnings date expected to be?

✔️Accepted answer: The next projected earnings date for BLCM is 4/4/2023 after close (stay tuned for a confirmed earnings date once announced).

  Suggested answer: Are you looking to know which fiscal year and quarter will be reported at the next BLCM earnings date? If so, it will be Q4 2022.

  Suggested answer: The BLCM next earnings report will be compared against the prior year Q4 earnings of 0.110/share on 0.00B of revenue.


How much is BLCM expected to earn at the next report?
When Bellicum Pharmaceuticals has their next earnings report, what are people expecting as far as their earnings?

✔️Accepted answer: Based on the data we get, analysts are looking for -0.930/share out of BLCM at next report.


On this page we presented the Bellicum Pharmaceuticals Next Earnings Date information for Bellicum Pharmaceuticals along with recent past earnings dates. For Q3 of 2022, BLCM reported earnings of -0.230/share, with the earnings report taking place on 11/10/2022. For Q2 of 2022, BLCM reported earnings of -0.130/share, with the earnings report taking place on 8/11/2022. For Q1 of 2022, BLCM reported earnings of -0.250/share, with the earnings report taking place on 5/12/2022. For Q4 of 2021, BLCM reported earnings of 0.110/share, with the earnings report taking place on 3/24/2022. For Q3 of 2021, BLCM reported earnings of 0.070/share, with the earnings report taking place on 11/4/2021. Based on these past earnings dates, the projected next earnings date for BLCM is 4/4/2023 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Bellicum Pharmaceuticals. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Bellicum Pharmaceuticals shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Bellicum Pharmaceuticals next earnings dates as well as any other stock out there in our coverage universe, to see when the next BLCM earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up BLCM's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the BLCM next earnings date.

Recommended: Funds Holding RAND, Kinder Morgan YTD Return, CMI Average Annual Return.

 

Bellicum Pharmaceuticals Next Earnings Date | www.NextEarningsDate.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.